PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Scheriproct - Haemorrhoids

PAD Profile : Scheriproct - Haemorrhoids

Keywords :
haemorrhoid creams, haemorrhoid ointments, haemorrhoidal treatments

Traffic Light Status

Status 1 of 1.

Status :
Green
Important Preferred
Formulations :
  • Ointment
  • Suppositories
Important Information :
Scheriproct ointment and suppositories are considerably less expensive than Proctosedyl and Anusol HC in primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Scheriproct ointment and suppositories have been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status. Scheriproct ointment and suppositories are considerably less costly than other brand equivalents such as Proctosedyl, Xyloproct, Uniroid HC and Ultraproct

Associated BNF Codes

01. Gastro-Intestinal System
01.07.02. Copound haemorrhoidal preparations with corticosteroid
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More